Correction: Discovery of novel disulfide-containing PD-1/PD-L1 inhibitor with in vivo influenza therapeutic efficacy
Abstract
The original version of this Article contained errors in Figure 2. Specifically in panel B, the sensorgrams for BMS-1 and compound 2 were mistakenly reversed within the figure panel. The original Figure 2 appears below. Fig. 2 Characterization of the PD-1/PDL1 interaction inhibitors by SPR. ( A ) Representative sensorgram of PD-1 on immobilized PD-L1. ( B ) Representative sensorgrams of PD-1 on immobilized PD-L1 in the presence or absence of tested compounds. As a control, 1% DMSO was used. ( C ) Representative sensorgrams of 2 on immobilized PD-L1 or PD-1. ( D ) The fitting curve of the response measured at equilibrium plotted against the compound 2 concentration. All experiments were repeated more than three times to ensure reliability. Full size image
Fields of Study & Subjects
Influenza Virus Research Studies
Cancer Immunotherapy and Biomarkers
vaccines and immunoinformatics approaches
Publication details
- Journal / source
- Scientific Reports
- Volume
- 16
- Issue
- 1
- Publication date
- 10 March 2026
- Language
- EN